Eleni Marouli, senior analyst at IHS, explains what has driven the growth in online advertising and spending.» Read More
The Fed is expected to take the historic but small step of slowing its easing programs and gradually steer markets toward more normal interest rates.
The SEC has approved the CEO pay ratio disclosure plan by a vote of 3 to 2, reports CNBC's Mary Thompson. And a check on all the market moving events from Europe today, with CNBC's Simon Hobbs.
Dino Kos, CLS Bank, and Barry Knapp, Barclays, discuss how the nation's budget deficit and the Fed's tapering decision will likely impact the markets.
The "Squawk on the Street" crew shares their thoughts on what investors should be watching throughout the trading day.
The "Squawk on the Street" news team reports on today's top business headlines, including Apple's new operating system; FedEx's strong earnings, and Starbuck's stand on the "open carry" gun policy.
Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell. Today, Cramer shares his thoughts on Goldman Sachs.
James Paulsen, Wells Capital Management, and Austan Goolsbee, University of Chicago, discuss the likely outcome of the Fed's tapering decision and the President's pick to head the Federal Reserve.
CNBC's Steve Liesman provides a preview of the Fed's decision on interest rates and possible tapering program. And Gary Stern, former Minneapolis Fed president, shares his thoughts on Fed policy and the looming budget debate on Capitol Hill.
Vasant Prabhu, Starwood Hotels & Resorts CFO, and Brian Tierney, American Electric Power CFO, share their thought on how the Fed's tapering policy and health care reform are impacting their businesses.
Jeff Mortimer, BNY Mellon Wealth Management, and Bill Smead, Smead Capital Management, discuss how the Fed's policy decisions are impacting the markets and the housing recovery.
To break down today's markets and discuss if tapering is already priced in, is Carol Roth, author of "The Entrepreneur Equation," and John Rutledge, Safanad.
Mad Money host Jim Cramer shares his final thoughts of the day.
BioMarin Pharmaceutical is the developer of orphan drugs for ultra-rare genetic disorders. The stock has been red hot and is up 245 percent in the last 3 years. JJ Bienaime, CEO, provides insight into the pharmaceutical company.
Mad Money host Jim Cramer looks at 2013's best performing healthcare and biotech stocks including Celgene and Regeneron.
Carrizo Oil & Gas is an independent oil producer that has many acres in Texas' Eagle Ford shale, Colorado's Niobrara shale, and Ohio's Utica's shale. With domestic oil stocks soaring, Chip Johnson, president and CEO of Carrizo Oil & Gas, discusses what is driving the stock higher.
Mad Money host Jim Cramer discusses what to think about as the Federal Reserve sets to release a statement on tapering.
The "Fast Money" team recaps the major CNBC headlines of the day, including Scott McNealy's, former chairman of Sun Microsystems, comments on charity, Microsoft's boost of dividend and look ahead at what to watch for in tomorrow's trading session.
Following Microsoft's announcement of a 22 percent dividend increase. CNBC's Kate Kelly spoke to ValueAct's Jeffrey Ubben about his new seat on the board at Microsoft. And John Netto, M3 Capital president, shares what you should be watching ahead of tomorrow's FOMC statement.
General Motors reveals its plans for a long-range electric car. Karen Finerman and Brian Kelly debate whether GM will be able to drive away with a piece of Tesla's market share. Mike Khouw provides the options perspective.
What to watch in tomorrow's trading session, with Chad Morganlander, Stifel; Brad Friedlander, Angel Oak Capital; and Dean Colucci, MLV and Company.